Urine was collected using standard clinical procedures (clean-catch or catheter). Both urine and serum were centrifuged and stored at −80°C. Enzyme-linked immunosorbent assays (ELISA) were performed using HNP1-3 Human ELISA Kit (Hycult Biotech-Plymouth Meeting, PA), Defensin-5 ELISA kit (Lifeome Biolabs-Oceanside, CA), Human Beta Defensin 2 ELISA Kit (Lifeome Biolabs), and LL-37 Human Elisa Kit (Hycult Biotech). For all but HNP 1-3, ELISA results were divided by urine creatinine (measured using the Oxford Biomedical Research creatinine microplate assay, Rochester Hills, MI) to standardize for urine concentration. Samples were run in duplicate. Serum 25-hydroxyvitamin D (25OHD) levels were measured by liquid chromatography-tandem mass spectrometry.
Human ll 37 elisa kit
The Human LL-37 ELISA kit is a quantitative enzyme-linked immunosorbent assay (ELISA) designed to measure the concentration of the human cathelicidin antimicrobial peptide LL-37 in various biological samples. The kit utilizes a specific antibody to capture and detect the target analyte.
Lab products found in correlation
14 protocols using human ll 37 elisa kit
Biomarker Detection in Urine and Serum
LL37 Quantification Using ELISA
Quantification of HBD1 and LL-37 Peptides
Comprehensive Biomarker Panel Analysis
Urinary creatinine was measured using Jaffé reaction as described previously (21 (link)). Briefly, 10 microliters of samples were mixed with 200 microliters of freshly prepared reagent consisted of 0.2 M sodium hydroxide and 25 mM picric acid (5:1 ratio). Absorbance was measured at 492 nm. Absorbance measured after 1st minute was subtracted from the absorbance measured at 6th minute.
Concentration of myeloperoxidase (MPO) in urine was determined using commercially available spectrophotometric assay according to manufactureŕs protocol (Human Myeloperoxidase DuoSet Elisa Kit, R&D Systems, Minneapolis, MN, United States). Absorbance was measured at 450 nm. Limit of detection was 62.5 pg/ml.
Similarly, cathelicidin in urine was measured by commercial Elisa kit as recommended by the manufactureŕs protocol (LL-37 Human Elisa kit, Hycult Biotech, Wayne, PA, United States). Urine samples were 10-times diluted. Absorbance was measure at 450 nm. Limit of detection was 0.14 ng/ml.
Quantification of HBD1 and LL-37 in A549 Cells
Evaluating LL37-mediated EV Immunomodulation
Quantifying LL-37, S1P, and LCN2 in Cells
Isolation and Culture of Human Immune Cells
Lipigenine Increases Cathelicidin (LL-37) Levels
EXAMPLE 7
A topical composition with Lipigenine™ was tested for its ability to increase concentration of Cathelicidin (LL37), an amphipathic alpha-helical peptide that plays an important role in defense against local infection and invasion of pathogens at sites of inflammation and wounds. The human LL-37 ELISA kit was obtained from Hycult Biotech (Cat#HK321). ELISA were performed according to the manufactory instructions of each kit by adding 100 μl/well of culture medium after overnight treatment. The results were measured using a colorimeter, absorbance was measured at 450 nanometers (nm) within 30 minutes. Wavelength correction was set to 570 nm.
The addition of Lipigenine™ showed increased LL-37 concentration at both 0.1% and 1% Lipigenine™ in solution as compared to the control. An increase in LL-37 concentration of 32% for a 0.1% Lipigenine™ formulation while an increase in LL-37 concentration of 38% was observed for a 1% Lipigenine™ formulation. These results are shown in
Lipigenine Increases Antimicrobial Peptide LL-37
Example 7
A topical composition with Lipigenine™ was tested for its ability to increase concentration of Cathelicidin (LL37), an amphipathic alpha-helical peptide that plays an important role in defense against local infection and invasion of pathogens at sites of inflammation and wounds. The human LL-37 ELISA kit was obtained from Hycult Biotech (Cat #HK321). ELISA were performed according to the manufactory instructions of each kit by adding 100 μl/well of culture medium after overnight treatment. The results were measured using a colorimeter, absorbance was measured at 450 nanometers (nm) within 30 minutes. Wavelength correction was set to 570 nm.
The addition of Lipigenine™ showed increased LL-37 concentration at both 0.1% and 1% Lipigenine™ in solution as compared to the control. An increase in LL-37 concentration of 32% for a 0.1% Lipigenine™ formulation while an increase in LL-37 concentration of 38% was observed for a 1% Lipigenine™ formulation. These results are shown in
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!